Ginascol John F 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Ginascol John F
Executive Vice President
Transactions
- Award
Common shares without par value
2022-02-18+17,247→ 130,921 total - Award
Option (right to buy)
2022-02-18+80,380→ 80,380 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (80,380 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,793 on February 18, 2023, 26,793 on February 18, 2024, and 26,794 on February 18, 2025.